Mature B-Cell Non-Hodgkin Lymphoma

Known as: Mature B-Cell Lymphoma, Mature B-Cell Non-Hodgkin's Lymphoma 
A non-Hodgkin lymphoma that originates from mature B lymphocytes. Representative examples include diffuse large B-cell lymphoma, follicular lymphoma… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2018
02420002018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Currently, there is no standardized treatment for adolescents, aged 15 years or older, with mature B-cell non-Hodgkin… (More)
Is this relevant?
Review
2017
Review
2017
Mature B-cell non-Hodgkin lymphoma (B-NHL) constitutes a collection of relatively rare pediatric malignancies. In order to… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Pediatric mature B-cell non-Hodgkin lymphomas (B-NHLs) are highly aggressive malignant tumors that are curable with chemotherapy… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2013
2013
The ANHL01P1 trial was undertaken to determine pharmacokinetics and safety following the addition of rituximab to French-American… (More)
  • figure 1
  • figure 2
Is this relevant?
2012
2012
PURPOSE Adolescents (age 15 to 21 years) compared with younger children with mature B-cell non-Hodgkin's lymphoma (NHL) have been… (More)
Is this relevant?
2010
2010
Mantle cell lymphoma (MCL) is a mature B-cell lymphoma characterized by expression of CD5, overexpression of Cyclin D1 as a… (More)
Is this relevant?
2008
2008
The aim of the present study was to estimate optimum chemotherapeutic regimens for high-grade mature B-cell lymphoma cases with… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2008
2008
Diagnosis and classification of aggressive mature B-cell lymphoma with atypical morphology remains a challenge. To identify… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
Some non-Hodgkin lymphomas show marked plasmacytic differentiation. In such cases, it may be difficult to differentiate these… (More)
Is this relevant?
2003
2003
BACKGROUND AND OBJECTIVES Short, intensive multiagent chemotherapy has resulted in significant progress in Burkitt's lymphoma and… (More)
  • table 1
  • table 2
  • table 4
  • figure 1
Is this relevant?